Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$181K Sell
3,700
-223,400
-98% -$11.2M ﹤0.01% 5289
2014
Q2
$12.8M Buy
227,100
+224,600
+8,984% +$11.5M 0.01% 1173
2014
Q1
$134K Sell
2,500
-27,100
-92% -$1.68M ﹤0.01% 5650
2013
Q4
$1.5M Buy
29,600
+27,600
+1,380% +$1.2M ﹤0.01% 3112
2013
Q3
$76K Buy
2,000
+1,900
+1,900% +$56.1K ﹤0.01% 6332
2013
Q2
$2K Buy
+100
New +$2.19K ﹤0.01% 9796

Other funds holding INCY

UBS's INCY Position: Q3 2014 in Review

UBS increased its Incyte (INCY) stake by 11% in Q3 2014, buying an estimated $1.86M and bringing the position to 363,029 shares worth $17.8M. The position accounts for 0.01% of the portfolio, ranked #1033.

UBS first reported a position in INCY in Q2 2013 and has held it in 6 quarters since. The position peaked at $18.4M in Q2 2014. 220 funds tracked by Wall St. Rank hold INCY as of Q3 2014.

  • UBS held 363,029 shares of Incyte worth $17.8M as of Q3 2014.
  • UBS bought 37,054 Incyte shares in Q3 2014, an estimated $1.86M.
  • Incyte made up 0.01% of UBS's portfolio in Q3 2014, its #1033 holding.
  • UBS first reported a position in Incyte in Q2 2013 and has held it in 6 quarters since.
  • UBS's Incyte position peaked at $18.4M in Q2 2014.
  • 220 funds tracked by Wall St. Rank held Incyte as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.